Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.
|
22859523 |
2012 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
<b>Introduction</b>: Cystic fibrosis (CF) is the most frequent lethal orphan disease and is caused by mutations in the CFTR gene.
|
31169041 |
2019 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
<i>Staphylococcus aureus</i> plays an important role in sepsis, pneumonia, wound infections, and cystic fibrosis (CF), which is caused by mutations of the cystic fibrosis transmembrane conductance regulator (<i>Cftr</i>).Pulmonary <i>S. aureus</i> infections in CF often occur very early and prior to colonization with other pathogens, in particular <i>Pseudomonas aeruginosa</i> Here, we demonstrate that CF mice are highly susceptible to pulmonary infections with <i>S. aureus</i> and fail to clear the pathogen during infection.<i>S. aureus</i> is internalized by <i>Cftr</i>-deficient macrophages in the lung, but these macrophages are unable to kill intracellular bacteria.
|
28289144 |
2017 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
<p>Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (<italic>CFTR</italic>) gene lead to cystic fibrosis (CF).
|
31590401 |
2019 |
Cystic Fibrosis
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations.
|
11737931 |
2001 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
- Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), which accounts for the cAMP-regulated chloride conductance of airway epithelial cells.
|
9922383 |
1999 |
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
BEFREE |
17 individuals who are homozygous for deletions, missense, stop or splice site mutations in the CFTR gene were investigated for clinical symptoms of CF and assessed in CFTR function by sweat test, nasal potential difference and intestinal current measurement.
|
18178635 |
2008 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
4/17 individuals (approximately 25% of cases) were found to suffer in fact from pseudo-Bartter syndrome resulting from congenital chloride diarrhea due to a novel homozygous mutation in the SLC26A3 gene, Pendred syndrome due to a known homozygous mutation in SLC26A4, Cystic Fibrosis (CF) due to a novel mutation in CFTR and apparent mineralocorticoid excess syndrome due to a novel homozygous loss of function mutation in HSD11B2 gene.1 case (5%) remained unsolved.
|
30760291 |
2019 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
40 CF patients and 40 normal individuals were screened for poly T polymorphism in intron 8 of CFTR gene using Reverse Dot Blot method which was also used to detect p.Phe508del among CF patients.
|
22430190 |
2012 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
67 unrelated cystic fibrosis (CF) patients were screened for some of the most common mutations of the CFTR gene.
|
7542223 |
1995 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and defective expression of CFTR protein in epithelial cells.
|
10567629 |
1999 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is one of the most common recessively inherited disorders in Caucasian populations and is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.
|
10612489 |
1999 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is caused by inherited mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-regulated chloride channel expressed in epithelial tissues.
|
10720935 |
2000 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene.
|
11069835 |
2000 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a disease that is caused by mutations within the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
|
11287314 |
2001 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.
|
12007216 |
2002 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
|
12226741 |
2002 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
|
12231476 |
2003 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is caused by mutations of the gene encoding for the CFTR (CF transmembrane conductance regulator) protein.
|
12409506 |
2002 |
Cystic Fibrosis
|
1.000 |
AlteredExpression
|
disease |
LHGDN |
Cystic fibrosis transport regulator is a cAMP-dependent chloride channel protein.
|
12485421 |
2002 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a systemic autosomal recessive inherited disorder that results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
|
12531063 |
2001 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is an autosomal recessive inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene and is characterised by pancreatic insufficiency and chronic bronchopulmonary infection.
|
12651880 |
2003 |